Welcome to Novo Nordisk in the United States


About Matthias von Herrath

Matthias von Herrath, MD, is vice president of Novo Nordisk’s type 1 diabetes team at the company’s Seattle research center. Matthias leads a diabetes translational unit, which is based on less conventional and innovative design for immune-based interventions.

Entries by Matthias von Herrath


What it’s like to GOBOLDLY every day

Matthias von Herrath, MD, Vice President of Novo Nordisk’s Diabetes R&D Center in Seattle, is one of the researchers featured in the GOBOLDLY campaign from the biopharmaceutical industry group, PhRMA.

Read the story

 


Explore more content

See all featured content